Please ensure Javascript is enabled for purposes of website accessibility

Tilray Has 64% Upside After "Perfect Match" Merger, Analyst Says

By Rich Duprey – May 7, 2021 at 10:16AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wall Street is mostly stoked about the cannabis stock's potential.

Wall Street is starting to swoon over Tilray (TLRY) now that the marijuana producer has closed its merger with Aphria

Jefferies analyst Owen Bennett just double-upgraded Tilray from underperform to buy, telling investors in a research note the cannabis company had completed the "perfect match," and asserting that it has tremendous upside potential in the U.S., Canada, and Europe.

As he resumed coverage of the pot stock, he set a price target of $23 per share on it, which is 64% above the $14.15 per share price where Tilray closed Thursday's session.

Person inspecting marijuana plant

Image source: Getty Images.

While the combined company will keep the Tilray name, it's really Aphria executives in charge of the business. Its CEO will hold the same position in the new Tilray, and he's also been appointed chairman.

Bennett describes the post-merger company as being far and away the front-runner in the Canadian marijuana market, and because of the strength of the cannabis portfolios both companies brought with them, it should continue to expand its market share.

He also believes Tilray is well-positioned to profit in the U.S. market as it's currently structured, and thinks that if the federal government finally legalizes marijuana in the next few years, the company will be able to capitalize on the opportunities that change will open up, too. 

Although Wall Street is fairly upbeat about Tilray, not everyone sees such tremendous upside. For example, Cannacord Genuity analyst Matt Bottomley says most of the cannabis company's dominance is already baked into its share price with a "sizable premium." Still, having resumed coverage of Tilray with a $17 per share price target, Bottomley is still anticipating a 20% upside from where it sits now.

Rich Duprey has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Jefferies Financial Group Inc. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Tilray Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/26/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.